Ticker: AGLE

Company: Aeglea BioTherapeutics, Inc.

Person: Cameron Turtle, director, officer

Transaction date: April 1, 2026

Reporting date: April 3, 2026

Average share price: 49.327488

Sold 15000.0 shares for 739912.32